Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Fangzhou Inc.

News headline image
Fangzhou’s AI-Powered Chronic Care Model Named to Fortune China’s Best Designs 2026
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Reports Sustained Revenue and Profit Growth as AI-Powered Chronic Care Strategy Gains Momentum
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Named to KPMG China Healthcare 50 for AI-Powered Chronic Disease Care
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Showcases AI-Powered Chronic Disease Management Solution With Tencent Health at Tencent Cloud Conference
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Ranked among 2025 Guangzhou AI Innovation “Most Promising Enterprises” for AI‑Powered Chronic Disease Services
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou and Tenry Pharmaceutical Forge Strategic Partnership to Advance AI-Powered Chronic Disease Care
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Showcases “AI+H2H” Chronic Disease Service Innovations at the National Intelligent Medicine Conference
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Publishes 2025 Annual Report, Advancing AI-Powered Chronic Care Strategy for 2026
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Inc. Appoints Healthcare Industry Veteran Wang Haijiao as Chief Executive Officer Following a Year of Record Growth and Profitability
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Reports Robust 2025 Financial Results, Boosted by AI Chronic Care Strategy
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou and Youcare Pharmaceutical Group Form Strategic Alliance to Advance AI-Driven Chronic Care Services
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou’s MaaS Platform Recognized as Industry Leader at Guangdong Digital Economy Conference
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou ’XingShi’ Large Language Model Highlighted Among China’s Most Anticipated Healthcare Models for 2026
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Wins Tencent Health ‘AI-Powered Future Award’ as MaaS Platform Drives AI Chronic Care
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Issues Positive Profit Forecast as AI-Driven Chronic Care Model Delivers First Full-Year Profit
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Raises HK$150 Million in Share Placement to Accelerate AI-Powered Chronic Care Platform
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou and Tencent Healthcare Launch Full-Stack AI Solution for Chronic-Disease Management
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Awarded “Golden Bull Award” for Leadership in AI-Powered Chronic Disease Management
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou, Novo Nordisk Launch Initiative for AI-Powered Diabetes and Weight Management Solutions at CIIE
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou’s “XingJie” LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Unveils “AI + Weight Management” Innovation at China’s Inaugural National-Level Weight Management Symposium in Beijing
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou’s ‘XingShi’ LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Named ‘Outstanding Growth Story in Hong Kong Stocks’ at China Capital Market Development Forum 2025
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Wins Gilead ‘Award of Excellence’ for AI-Driven Chronic Disease Management
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Unveils “XingShi” LLM to Advance AI-Driven Chronic Disease Management
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou and Innovent Biologics Form Strategic Alliance for AI-Powered Weight Management Solutions
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Secures 2nd National Science Foundation Project Approval, Deepens AI-Driven Healthcare Research
From Fangzhou Inc.
Via GlobeNewswire
News headline image
Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand
From Fangzhou Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.